[1] KAUR I P，SMITHA R. Penetration enhancers and ocular bioadhesives： Two new avenues for ophthalmic drug delivery[J] .Drug Dev Ind Pharm，2002，28（4）：353-369. [2] WU W，LU B. Research advances in ophthalmic liposome delivery system[J] .West China J Pharm Sci（华西药学杂志），1999，14（5-6）： 370-374. [3] MEISNER D，MEZEI M. Liposome ocular delivery systems[J] . Adv Drug Deliv Rev，1995，16（1）：75-93. [4] NAGARSENKER M S，LONDHE V Y，NADKARNI G D. Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery[J] .Int J Pharm，1999，190（1）：63-71. [5] LAW S L，HUANG K J，CHIANG C H. Acyclo vir-containing liposomes for potential ocular delivery. Corneal penetration and absorlption[J] .J Controlled Release，2000，63（1-2）： 135-140. [6] FISHMAN P，PEYMAN G A，HENDRICKS R，et al. Liposome-encapsulated 3H-5FU in rabbits [J] .Int Ophthalmol，1989，13（5）：361-365. [7] SUN K X，QI Y H，WU R J，et al. Studies on preparation of cyclosporine A-loaded liposomes and their in-vitro corneal penetration[J] .Chin Pharm J(中国药学杂志)，2003，38（4）： 31-34. [8] SUN K X，QI Y H，WU R J，et al. Ocular absorption and distribution of liposomal ciclosporin in rabbits [J] .Chin J Clin Pharm (中国临床药学杂志)，2004，13（1）： 22-25. [9] ZIMMER A，KREUTER J. Microspheres and nanoparticles used in ocular delivery systems[J] .Adv Drug Deliv Rev，1995，16（1）： 61-73. [10] ZIMMER A K，ZERBE H，KREUTER J. Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye I.In vitro and in vivo characterization[J] .J Controlled Release，1994，32（1）： 57-70. [11] DE CAMPOS A M，SANCHEZ A，GREF R，et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa[J] .Euro J Pharm Sci，2003，20（1）： 73-81. [12] DE CAMPOS A M，SANCHEZ A，ALANSO M J. Chitosan nanoparticles： a new vehicle for the improvement of the delivery of drugs to the ocular surface[J] .Int J Pharm，2001，224（1-2）： 159-168. [13] MERODIO M，IRACHE J M，VALAMANESH F，et al. Ocular disposition and tolerance of Ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats[J] .Biomaterials，2002，23（7）： 1587-1594. [14] DAI L，SONG L，DENG A L，et al. Optimizing the preparation procedure of norfloxacin polybutylcyanoacylate nanoparticles[J] .Chin Hos Pharm J (中国医院药学杂志)，1999，19（12）： 709-711. [15] DAI L，SONG L，JIANG X H. The study on the quality of ophthalmic NFLX-PBCA-NP[J] .China Pharmacy (中国药房)，1999，10（5）：208-209. [16] DAI L，SONG L，JIANG X H. Assay method of enbedding ratio and drug loading of NFLX PBCANP [J] .West China J Pharm Sci（华西药学杂志），2000，15（4）：304-305. [17] STATE FOOD AND DRUG ADMINISTRA- TION. Drugs（including packaging materials）[DB/OL] . Http：//app1.sfda.gov.cn/webportal/por tal.po/2004-01-10. [18] ZIMMER A K，MAINCENT P，THOUVENOT P，et al. Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles[J] . Int J Pharm，1994，110（3）： 211-222. [19] VANDAMME T F. Microemulsions as ocular drug delivery systems：recent developments and future challenges[J] .Prog Retin Eye Res，2002，21（1）：15-34. [20] BENITA S，MUCHTAR S. Ophthalmic compositions： EP，0521799[P] . 1993-01-07. [21] RADOMSKA A，DOBRUCKI R. The use of some ingredients for microemulsion preparation containing retinal and its esters[J] .Int J Pharm，2000，196（2）： 131-134. [22] MELAMED S，KURTZ S，GREENBAUM A，et al. Adaprolol maleate in submicron emulsion，a novel soft β-blocking agent，is safe and effective in human studies[J] .Invest Ophthalmol Vis Sci，1994，35（4）： 1387-1392. [23] GARTY N，LUSKY M. Pilocarpine in submicron emulsion formulation for treatment of ocular hypertension： a phase Ⅱ clinical trial. Invest[J] . Ophthalmol Vis Sci，1994，35（4）： 2175-2182. [24] ELBAZ E，ZEEVI A，KLANG S H，et al. Positively charged submicron emulsions，a new type of colloidal drug carrier[J] .Int J Pharm，1993，96（1-3）：R1-R6. [25] KLANG S H，FRUCHT-PERY J，HOFFMAN A，et al. Physicochemical characterization and acute toxicity evaluation of a positively charged submicron emulsion vehicle[J] .J Pharm Pharmacol，1994，46（1-3）： 986-992. [26] LALLEMAND F，FELT-BAEYENS O，BESSEGHIR K，et al. Cyclosporine a delivery to the eye： A pharmaceutical challenge[J] .Eur J Pharm Bio，2003，56（3）：307-318. [27] ALLERGAN. Refresh enduraTM lubri- cant eye drops[EB/OL] .http：//www.allergen.com/site/products/consumers/home.asp/2005.